Author

G. Bond

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. H. Kroemer· 1 shared A. Khanna· 1 shared A. Protheroe· 1 shared A. Ryan· 1 shared B. Spishock· 1 shared B. W. Higgs· 1 shared C. Ashokkumar· 1 shared C. Loveday· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. H. Kroemer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients

C. Ashokkumar, V. Rohan, A. H. Kroemer, S. Rao, G. Mazariegos, B. W. Higgs, S. Nadig, J. Almeda, H. Dhani, K. Khan, N. Yazigi, U. Ekong, S. Kaufman, M. M. Betancourt-Garcia, K. Mukund, , R. Sindhi

This study evaluates T-cell and antibody immunity to SARS-CoV-2 in transplant recipients, finding impaired responses and increased CMV co-infection risk post-infection.

bioRxiv · May 3, 2021 · PreprintImmunology

Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response

P. Zhang, I. Kitchen-Smith, L. Xiong, G. Stracquadanio, K. Brown, P. Richter, M. Wallace, E. Bond, N. Sahgal, S. Moore, S. Nornes, S. De Val, M. Surakhy, D. Sims, X. Wang, , G. Bond

The paper investigates interactions between germline and somatic variants in the p53 pathway to show their combined effects on cancer risk, progression, and treatment response.

bioRxiv · Nov 9, 2019Cancer Biology